CHMP adopts positive opinion for melanoma treatment Imlygic
23 October 2015 | By Victoria White
If approved by the European Commission, Imlygic would be the first in a class of novel agents known as oncolytic immunotherapies...
List view / Grid view
News
New ProtectionPlus module for 21 CFR Part 11 compliance with HORIBA Raman systems
23 October 2015 | By HORIBA Scientific
HORIBA Scientific, global leader in Raman spectroscopy systems for over 50 years, announces the release of their new ProtectionPlus module for the acclaimed LabSpec 6 Spectroscopy Suite...
Ipsen announces additional Phase III study results for Dysport
23 October 2015 | By Victoria White
The Phase III study evaluated the investigational use of Dysport for the treatment of spastic equinus foot, a condition associated with cerebral palsy in children aged 2-17...
EC maintains orphan drug designation for Basilea’s isavuconazole
23 October 2015 | By Victoria White
Isavuconazole will benefit from ten years of market exclusivity associated with orphan medicinal product status in the European Union...
MHRA seizes huge haul of unlicensed medicines
23 October 2015 | By Victoria White
MHRA Enforcement officers seized nearly £1 million worth of unlicensed erectile dysfunction medicines from an address in Slough...
Global Clostridium difficile infections market to hit $1.5b by 2024
23 October 2015 | By Victoria White
GlobalData says this increase will be driven by the modest uptake of patent-protected, Clostridium difficile infection-specific antibiotics and the arrival of novel non-antibiotic approaches...
Gilead announces Phase 3 results for investigational HIV treatment Genvoya
22 October 2015 | By Victoria White
Genvoya was found to be statistically non-inferior to Stribild based on percentages of patients with HIV-1 RNA levels less than 50 copies/mL...
MacroGenics and Merck to study margetuximab and pembrolizumb in gastric cancer
22 October 2015 | By Victoria White
Trial startup activities are underway and MacroGenics expects to begin enrolling patients by the first quarter of 2016...
New UV-Vis Spectrophotometer simplifies sample quality decisions
Life scientists who work with DNA, RNA and proteins can make educated decisions about sample suitability in experiments using a standalone, microvolume spectrophotometer for accurate quantitation and purity measurements to ensure downstream application success.
Gilead’s GS-5734 given to UK Ebola patient
22 October 2015 | By Victoria White
GS-5734 was discovered as part of Gilead’s programme to screen compounds in its libraries for activity against a range of potential emerging viruses, including Ebola...
Piramal’s Vivek Sharma wins CEO of the Year at CPhI Pharma Awards
22 October 2015 | By Victoria White
The CPhI Pharma Awards recognise life sciences firms that turn inspiration into innovation, and celebrate thinkers and creators that are breaking new ground in formulation, process development, packaging, technology, and more...
AstraZeneca and Lilly expand immuno-oncology collaboration
22 October 2015 | By Victoria White
Under the terms of the expanded agreement, AstraZeneca and Lilly will evaluate the safety and efficacy of a range of additional combinations across the companies’ portfolios...
Gene test could predict spread of breast cancer to the brain
21 October 2015 | By Victoria White
Research has found that women whose breast cancer had begun to spread and who tested positive in the αB-crystallin test were three times more likely to have disease that spread to the brain...
NICE recommends ezetimibe for hypercholesterolaemia
21 October 2015 | By Victoria White
The new draft guidance is different to the original 2007 guidance because it reflects the fact that current clinical practice has a greater emphasis on managing CVD risk rather than meeting target cholesterol levels...
FDA approves Coagadex for hereditary Factor X deficiency
21 October 2015 | By Victoria White
Until this orphan drug approval, no specific coagulation factor replacement therapy was available in the US for patients with hereditary Factor X deficiency...
